Evolving Dynamic Biomarkers for Prediction of Immune Responses to Checkpoint Inhibitors in Cancer

Immune checkpoint inhibitors (ICIs) have been approved as first or second line therapy in a large group of cancers. However, the observation of potentially long-lasting responses was restricted to limited subset of patients. Efforts have been made to identify predictive factors of response to ICIs i...

Descripción completa

Detalles Bibliográficos

Autores principales:	Raza, Afsheen, Merhi, Maysaloun, Relecom, Allan, Fernandes, Queenie, Inchakalody, Varghese, Gul, Abdul Rahman Zar, Uddin, Shahab, Homsi, Mohammed Ussama Al, Dermime, Said
Formato:	Capítulo de libro
Lenguaje:	inglés
Publicado:	IntechOpen 2021
Materias:	Health Sciences
Acceso en línea:	https://www.intechopen.com/chapters/75496
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!